In the field of cancer research, single-cell imaging technology faces a critical technical challenge: how to maintain cell viability under high-flow conditions while achieving precise switching between multiple fluids.

Hongke’s Elveflow microfluidic system successfully addressed a key technical challenge faced by the University of Hong Kong during its research—achieving precise control of high flow rates (100–400 μL/min) and rapid multi-fluid switching while maintaining cell viability. This technological breakthrough not only validates the outstanding performance of Hongke’s Elveflow equipment in high-end scientific research applications but also demonstrates its stability and reliability in complex experimental environments.